...
首页> 外文期刊>Phytotherapy research: PTR >Polyphenols from Artemisia annua L Inhibit Adhesion and EMT of Highly Metastatic Breast Cancer Cells MDA-MB-231
【24h】

Polyphenols from Artemisia annua L Inhibit Adhesion and EMT of Highly Metastatic Breast Cancer Cells MDA-MB-231

机译:青蒿多酚抑制高度转移性乳腺癌细胞MDA-MB-231的黏附和EMT

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Recent evidence suggests that polyphenolic compounds from plants have anti-invasion and anti-metastasis capabilities. The Korean annual weed, Artemisia annua L., has been used as a folk medicine for treatment of various diseases. Here, we isolated and characterized polyphenols from Korean A. annua L (pKAL). We investigated anti-metastatic effects of pKAL on the highly metastatic MDA-MB-231 breast cancer cells especially focusing on cancer cell adhesion to the endothelial cell and epithelial-mesenchymal transition (EMT). Firstly, pKAL inhibited cell viability of MDA-MB-231 cells in a dose-dependent manner, but not that of human umbilical vein endothelial cells (ECs). Polyphenols from Korean A. annua L inhibited the adhesion of MDA-MB-231 cells to ECs through reducing vascular cell adhesion molecule-1 expression of MDA-MB-231 and ECs, but not intracellular adhesion molecule-1 at the concentrations where pKAL did not influence the cell viability of either MDA-MB-231 cells nor EC. Further, pKAL inhibited tumor necrosis factor-activated MDA-MB-231 breast cancer cell invasion through inhibition of matrix metalloproteinase-2 and matrix metalloproteinase-9 and EMT. Moreover, pKAL inhibited phosphorylation of Akt, but not that of protein kinase C. These results suggest that pKAL may serve as a therapeutic agent against cancer metastasis at least in part by inhibiting the cancer cell adhesion to ECs through suppression of vascular cell adhesion molecule-1 and invasion through suppression of EMT. Copyright (c) 2016 John Wiley & Sons, Ltd.
机译:最近的证据表明,植物中的多酚类化合物具有抗侵袭和抗转移的能力。韩国一年生杂草Artemisia annua L.已被用作治疗各种疾病的民间药物。在这里,我们分离和表征了来自韩国红曲霉(pKAL)的多酚。我们研究了pKAL对高度转移的MDA-MB-231乳腺癌细胞的抗转移作用,尤其关注癌细胞对内皮细胞的粘附和上皮-间质转化(EMT)。首先,pKAL以剂量依赖性方式抑制MDA-MB-231细胞的细胞生存力,但不抑制人脐静脉内皮细胞(EC)的剂量。来自朝鲜红曲霉的多酚通过减少MDA-MB-231和ECs的血管细胞粘附分子-1表达,但不抑制pKAL浓度下的细胞内粘附分子-1,从而抑制MDA-MB-231细胞对ECs的粘附不会影响MDA-MB-231细胞或EC的细胞活力。此外,pKAL通过抑制基质金属蛋白酶-2和基质金属蛋白酶-9以及EMT来抑制肿瘤坏死因子激活的MDA-MB-231乳腺癌细胞侵袭。而且,pKAL抑制了Akt的磷酸化,但不抑制蛋白激酶C的磷酸化。这些结果表明,pKAL至少部分地通过抑制血管细胞粘附分子的作用来抑制癌细胞对EC的粘附,从而可以作为抗癌转移的治疗剂1和通过抑制EMT入侵。版权所有(c)2016 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号